AAMT, D., EM, v. M., YRJ, W., M, E. A., K, F., CMA, R., . . . REA, M. (2020). Comparison between coagulation factor VIII quantified with one-stage activity assay and with mass spectrometry in haemophilia A patients: Proof of principle. International journal of laboratory hematology, 42(6), 819. https://doi.org/10.1111/ijlh.13283
Chicago Style (17th ed.) CitationAAMT, Donners, van Maarseveen EM, Weetink YRJ, El Amrani M, Fischer K, Rademaker CMA, Egberts TCG, Huisman A, and Musson REA. "Comparison Between Coagulation Factor VIII Quantified with One-stage Activity Assay and with Mass Spectrometry in Haemophilia A Patients: Proof of Principle." International Journal of Laboratory Hematology 42, no. 6 (2020): 819. https://doi.org/10.1111/ijlh.13283.
MLA (9th ed.) CitationAAMT, Donners, et al. "Comparison Between Coagulation Factor VIII Quantified with One-stage Activity Assay and with Mass Spectrometry in Haemophilia A Patients: Proof of Principle." International Journal of Laboratory Hematology, vol. 42, no. 6, 2020, p. 819, https://doi.org/10.1111/ijlh.13283.